| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500040 | Farmacia Hospitalaria | 2012 | 7 Pages |
Abstract
The results of our study show the important role of bortezomib in the treatment of multiple myeloma, with response rates and side effects comparable to published data, although the conditions for using it in clinical practice are not yet recognized in the guidelines for use.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
J.C. Titos-Arcos, J. León-Villar, F. de Arriba de la Fuente, M.J. Moreno Belmonte, M.D. Iranzo Fernández,